The independent source for health policy research, polling, and news.
561 - 580 of 1,300 Results
President Donald Trump made substantial changes to the nation鈥檚 health care system using executive branch authority. But reversing policies that Democrats oppose would take time and personnel resources, competing with other priorities of the new administration.
Democratic victories in two runoff elections in Georgia will give Democrats control of the Senate starting Jan. 20, which means they will be in charge of both houses of Congress and the White House for the first time since 2010. Meanwhile, covid continues to run rampant while vaccine distribution lags. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Mary Ellen McIntire of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Covid-19, distrust of police and cheap narcotics have turned parts of the wealthy city into cesspools of filth and drug overdose. City officials and residents profoundly disagree on what needs to be done.
KHN Editor-in-Chief Elisabeth Rosenthal discusses the bottlenecks in distributing covid vaccines on NPR's 鈥淥n My Mind鈥 podcast with host Diane Rehm.
Most private insurance will be required to cover drugs, like Truvada, that offer protection against HIV infection, without making plan members share the cost.
A growing body of research shows that overuse and misuse of antibiotics in children鈥檚 hospitals is helping fuel superbugs, which typically strike frail seniors but are increasingly infecting kids. And the pandemic is making things worse.
While many private insurers cap what members pay in health costs, Medicare does not. Democrats and Republicans in Congress have proposed annual limits ranging from $2,000 to $3,100. But there鈥檚 disagreement about how to pay for that cost cap.
There are already signs that the distribution of the COVID vaccines will be messy, confusing and chaotic.
The coronavirus pandemic colored just about everything in 2020. But there was other health policy news that you either never heard or might have forgotten about: the Affordable Care Act going before the Supreme Court with its survival on the line; ditto for Medicaid work requirements. And a surprise ending to the 鈥渟urprise bill鈥 saga. Joanne Kenen of Politico, Anna Edney of Bloomberg News and Sarah Karlin-Smith of Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more.
Months before federal officials authorized experimental vaccines to ward off the coronavirus in humans, scientists tried a veterinary vaccine in endangered ferrets. Drugmakers are researching similar efforts for other animals proving vulnerable to the virus, such as farmed minks, in part to guard against virus mutations that could pose new risks to people.
After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.
Hospitals and nursing homes must decide who gets the initial doses as the U.S. heads into the biggest vaccination effort in history. There鈥檚 a lot left to figure out.
Everyone 鈥 from toilet paper manufacturers to patient advocates 鈥 is lobbying state advisory boards, arguing their members are essential, vulnerable or both 鈥 and, thus, most deserving of an early vaccine.
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to 鈥淏eanie Baby鈥-level urgency.
Fears over COVID-19 have contributed to a slump in inoculations among children. Now the federal government is looking to pharmacists for help, but many of them do not participate in a program that offers free shots to half the kids in the U.S.
COVID-19鈥檚 鈥渓ong haulers鈥 鈥 patients with lingering effects of the disease 鈥 have joined the ranks of Americans with preexisting conditions. For those shopping for health coverage on the individual market, here鈥檚 help navigating an uncharted insurance landscape.
Widespread COVID testing has revealed uncomfortable truths about medical tests: A test result is rarely a definitive answer, but instead a single clue. A result may be falsely positive or negative, or it may show an abnormality that doesn鈥檛 matter. And as COVID testing has made too clear, even an accurate, meaningful result is useless unless it鈥檚 acted on appropriately.
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
A proposal in Washington state would use right-to-try laws to allow terminally ill patients access to psilocybin 鈥 the famed magic mushrooms of America鈥檚 psychedelic 鈥60s 鈥 to ease depression and anxiety.
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
漏 2026 KFF